ArticleFrontiers in cellular and infection microbiology2026
Genomic analysis reveals multi-level resistance network linking oxidative stress pathway mutations to cefiderocol resistance and clonal evolution in
Article in Frontiers in cellular and infection microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Resistance to cefiderocol (CFDC), a novel siderophore-cephalosporin, remains poorly understood. We aimed to explore mutations in oxidative stress (OS) pathways in Methods: A total of 282 KPN strains from the United Arab Emirates were tested for susceptibility to various antibiotics, including CFDC. Afterward, 96 representative strains were subjected to whole-genome sequencing and bioinformatic analyses to examine 51 genes across six functional categories (OxyR, SoxRS, iron regulation, efflux pumps, DNA repair, and penicillin-binding proteins). Genotypic and phenotypic results were correlated to explore significant associations with CFDC susceptibility. Results: CFDC demonstrated high Conclusions: Coordinated interactions across iron regulation, OS, and efflux pathways are associated with reduced susceptibility to CFDC. The negative correlation between OxyR/DNA repair mutations and CFDC MICs suggests that intact OS defenses paradoxically reduce CFDC efficacy. OS pathway integrity may modulate CFDC susceptibility, informing future strategies to preserve CFDC efficacy. The identification of specific mutations linked to CFDC resistance provides potential biomarkers for surveillance and therapeutic targeting, underscoring the interplay between OS responses and antimicrobial resistance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.